Zafrani ES - Search Results

1

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.

Degott C, Zafrani ES, Callard P, Balkau B, Poupon RE, Poupon R. Degott C, et al. Among authors: zafrani es. Hepatology. 1999 Apr;29(4):1007-12. doi: 10.1002/hep.510290444. Hepatology. 1999. PMID: 10094939 Clinical Trial.

2

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.

Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES. Poupon RE, et al. Among authors: zafrani es. Hepatology. 1996 Nov;24(5):1098-103. doi: 10.1002/hep.510240520. Hepatology. 1996. PMID: 8903382 Clinical Trial.

3

[Non-neoplastic diseases of the intrahepatic biliary tracts in adults].

Zafrani ES, Degott C. Zafrani ES, et al. Ann Pathol. 1995;15(5):348-56. Ann Pathol. 1995. PMID: 8540920 Review. French. No abstract available.

4

Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon.

Poupon RE, Bonnand AM, Queneau PE, Trépo C, Zarski JPí, Vetter D, Raabe JJ, Thieffin G, Larrey D, Grangé JD, Capron JP, Serfaty L, Chrétien Y, St Marc Girardin MF, Mathiex-Fortunet H, Zafrani ES, Guéchot J, Beuers U, Paumgartner G, Poupon R. Poupon RE, et al. Among authors: zafrani es. Scand J Gastroenterol. 2000 Jun;35(6):642-9. doi: 10.1080/003655200750023624. Scand J Gastroenterol. 2000. PMID: 10912666 Clinical Trial.

5

A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.

Ziol M, Nhieu JT, Roudot-Thoraval F, Métreau JM, Deugnier Y, Dhumeaux D, Zafrani ES. Ziol M, et al. Among authors: zafrani es. J Hepatol. 1996 Dec;25(6):833-41. doi: 10.1016/s0168-8278(96)80286-8. J Hepatol. 1996. PMID: 9007710 Clinical Trial.

6

Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis.

Pawlotsky JM, Andre C, Metreau JM, Beaugrand M, Zafrani ES, Dhumeaux D. Pawlotsky JM, et al. Among authors: zafrani es. Hepatology. 1992 Jul;16(1):127-31. doi: 10.1002/hep.1840160121. Hepatology. 1992. PMID: 1319948

7

Primary biliary cirrhosis: proposal for a new simple histological scoring system.

Wendum D, Boëlle PY, Bedossa P, Zafrani ES, Charlotte F, Saint-Paul MC, Michalak S, Chazouillères O, Corpechot C. Wendum D, et al. Among authors: zafrani es. Liver Int. 2015 Feb;35(2):652-9. doi: 10.1111/liv.12620. Epub 2014 Jul 8. Liver Int. 2015. PMID: 24939754

8

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

Hézode C, Roudot-Thoraval F, Nguyen S, Grenard P, Julien B, Zafrani ES, Pawlotsky JM, Dhumeaux D, Lotersztajn S, Mallat A. Hézode C, et al. Among authors: zafrani es. Hepatology. 2005 Jul;42(1):63-71. doi: 10.1002/hep.20733. Hepatology. 2005. PMID: 15892090

9

[Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease].

Allory Y, Métreau J, Zafrani E. Allory Y, et al. Ann Pathol. 2000 Jan;20(1):52-5. Ann Pathol. 2000. PMID: 10648987 French.

10

Image of the month. Albinism, cyclic neutropenia, and ceroid pigment in the liver.

Calderaro J, Zafrani ES. Calderaro J, et al. Among authors: zafrani es. Hepatology. 2009 Jul;50(1):314-5. doi: 10.1002/hep.23080. Hepatology. 2009. PMID: 19554547 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters